Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and Teva and is included […]
Source
Annual Drug Patent Expirations for INLYTA Inlyta is a drug marketed by Pf Prism Cv and is included in one […]
Source
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in […]
Source
Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs. […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET Read Post »
Annual Drug Patent Expirations for INVOKAMET+XR Invokamet Xr is a drug marketed by Janssen Pharms and is included in one […]
Source
New patent expiration for Janssen Pharms drug INVOKAMET XR Read Post »
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. […]
Source
New patent expiration for Helsinn Hlthcare drug ALOXI Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Croatia? Read Post »
The biotech industry is known for its high-risk, high-reward nature, requiring substantial initial capital to support extensive research and development
The process of obtaining a drug patent can be daunting, especially for those without a background in law or intellectual property. However, understanding the intricacies of this process is crucial for pharmaceutical companies seeking to protect their i…
Demystifying the Drug Patent Application Process Read Post »
Get new actionable insights and updates from BiotechBlog
